{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:29:57Z","timestamp":1787567397340,"version":"build-2736575974"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drug-coated balloons (DCB) represent a novel therapeutic approach for treating native coronary artery disease. However, the clinical outcomes of DCB in patients with left anterior descending (LAD) artery stenosis proximal to a myocardial bridge (MB) remain unclear. This study aims to investigate the effects of DCB in patients with LAD artery stenosis proximal to MB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This retrospective cohort study included consecutive patients with LAD artery stenosis proximal to MB who underwent DCB or drug-eluting stent (DES) procedures between January 2020 and July 2021. The DCB group comprised 30 patients treated with DCB alone, while the DES group included 105 patients treated with DES alone. Major adverse cardiac events (MACEs) during a median follow-up of 507 days (IQR 391.5\u2013622.0 days) were defined as a composite of unstable angina requiring hospitalization, acute myocardial infarction, cardiac death, and target lesion revascularization (TLR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both groups exhibited generally comparable baseline clinical and lesion characteristics, except for age and MB systolic compression. Over a median follow-up of 507 days (IQR 391.5\u2013622.0 days), Kaplan\u2013Meier survival analysis revealed no statistically significant difference in MACE-free survival rates between the two groups (73.96%, 95% CI 55.8\u201398.0 vs. 82.49%, 95% CI 73.9\u201390.8; Log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.678). Cox proportional regression analysis showed no statistically significant difference in MACEs between DCB and DES patients (HR\u2009=\u20091.58, 95% CI\u2009=\u20090.56\u20134.45,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.383).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this exploratory retrospective study, we did not detect a statistically significant advantage of DCB over DES in treating LAD stenosis proximal to MB. Given the limited sample size, these findings should be considered preliminary and do not support DCB as a reasonable alternative to DES. Larger prospective studies are warranted to validate the potential role of DCB in this specific anatomical setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1830690","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:10:32Z","timestamp":1787562632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of drug coated balloon on left anterior descending artery stenosis at proximal to myocardial bridge"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuqing","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Cardiology, Heze Municipal Hospital","place":["Heze, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heze Municipal Hospital","place":["Heze, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaipeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heze Municipal Hospital","place":["Heze, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heze Municipal Hospital","place":["Heze, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Chao-Yang Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Chao-Yang Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Chao-Yang Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Third Affiliated Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Third Affiliated Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.jacc.2021.09.859","article-title":"Myocardial bridging: diagnosis, functional assessment, and management: JACC state-of-the-art review","volume":"78","author":"Sternheim","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.21037\/atm.2020.02.24","article-title":"Associations of myocardial bridging with adverse cardiac events: a meta-analysis of published observational cohort studies involving 4,556 individuals","volume":"8","author":"Zhu","year":"2020","journal-title":"Ann Transl Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/ehjacc\/zuac047","article-title":"Myocardial bridging is significantly associated to myocardial infarction with non-obstructive coronary arteries","volume":"11","author":"Matta","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1253\/circj.cj-10-1278","article-title":"Significance of the anatomical properties of a myocardial bridge in coronary heart disease","volume":"75","author":"Ishikawa","year":"2011","journal-title":"Circ J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/CIRCULATIONAHA.108.820720","article-title":"Anatomic properties of myocardial bridge predisposing to myocardial infarction","volume":"120","author":"Ishikawa","year":"2009","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.hlc.2014.02.021","article-title":"Impact of myocardial bridging on the long-term clinical outcomes of patients with left anterior descending coronary artery disease treated with a drug-eluting stent","volume":"23","author":"Lee","year":"2014","journal-title":"Heart Lung Circ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1536\/ihj.17-179","article-title":"The outcome of percutaneous coronary intervention for significant atherosclerotic lesions in segment proximal to myocardial bridge at left anterior descending coronary artery","volume":"59","author":"Hao","year":"2018","journal-title":"Int Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4244\/EIJV10I1A10","article-title":"A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results","volume":"10","author":"L\u00f3pez M\u00ednguez","year":"2014","journal-title":"EuroIntervention"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","article-title":"Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study","volume":"96","author":"Cortese","year":"2010","journal-title":"Heart"},{"key":"B10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00004424-196805000-00009","article-title":"Angiographic appearance of myocardial bridging of the coronary artery","volume":"3","author":"Amplatz","year":"1968","journal-title":"Invest Radiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"53","author":"Valgimigli","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/1556-4029.13665","article-title":"Myocardial bridging: a meta-analysis of prevalence","volume":"63","author":"Hostiuc","year":"2018","journal-title":"J Forensic Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.5114\/pjr.2019.90370","article-title":"The prevalence of myocardial bridging on multidetector computed tomography and its relation to coronary plaques","volume":"84","author":"Rajendran","year":"2019","journal-title":"Pol J Radiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tcm.2022.06.002","article-title":"Update review on myocardial bridging: new insights","volume":"34","author":"Matta","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"B15","first-page":"73","article-title":"Stent procedure complicated by thrombus formation distal to the lesion within a muscle bridge","volume":"43","author":"Agirbasli","year":"1998","journal-title":"Cathet Cardiovasc Diagn"},{"key":"B16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jbiomech.2019.01.021","article-title":"Myocardial bridging and endothelial dysfunction - computational fluid dynamics study","volume":"85","author":"Javadzadegan","year":"2019","journal-title":"J Biomech"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B18","doi-asserted-by":"publisher","first-page":"935263","DOI":"10.3389\/fcvm.2022.935263","article-title":"Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions","volume":"9","author":"Yang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jacc.2019.12.046","article-title":"Drug-coated balloon for de novo coronary artery disease: jACC state-of-the-art review","volume":"75","author":"Yerasi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5114\/aic.2024.139970","article-title":"Stent fracture due to myocardial bridging causes cockboat deformity with large ischaemic myocardium","volume":"20","author":"Hanci","year":"2024","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"B21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4330\/wjc.v12.i2.91","article-title":"Plaque herniation after stenting the culprit lesion with myocardial bridging in ST elevation myocardial infarction: a case report","volume":"12","author":"Ma","year":"2020","journal-title":"World J Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3390\/medicina61081470","article-title":"Coronary angioplasty with drug-coated balloons: pharmacological foundations, clinical efficacy, and future directions","volume":"61","author":"Chioncel","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jacasi.2025.02.017","article-title":"Drug-coated balloons-based intervention for coronary artery disease: the second report of Asia-Pacific consensus group","volume":"5","author":"Her","year":"2025","journal-title":"JACC Asia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2217\/fca.11.56","article-title":"Current status, challenges and future directions of drug-eluting balloons","volume":"7","author":"Barbash","year":"2011","journal-title":"Future Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jconrel.2016.08.018","article-title":"Materials technology in drug eluting balloons: current and future perspectives","volume":"239","author":"Xiong","year":"2016","journal-title":"J Control Release"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S0140-6736(24)01594-0","article-title":"Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE i): an open-label, randomised, non-inferiority trial","volume":"404","author":"Gao","year":"2024","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S0140-6736(24)01454-5","article-title":"Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea","volume":"404","author":"Hong","year":"2024","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.26599\/1671-5411.2024.02.001","article-title":"Chinese Expert consensus on the clinical application of drug-coated balloon (2nd) edition)","volume":"21","author":"Expert","year":"2024","journal-title":"J Geriatr Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1830690\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:10:33Z","timestamp":1787562633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1830690\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":29,"alternative-id":["10.3389\/fcvm.2026.1830690"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1830690","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1830690"}}